Inventor · disambiguated record
Jean-Christophe Currie
Also filed as: CURRIE JEAN-CHRISTOPHE
3 granted patents·9 pending applications·10 citations·filing 2012–2025
65Inventor score
Top patents by PatentIndex Score
12 records- 0192US11780882B2Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2021·Granted Oct 10, 2023·3 cites·21 claims
- 0290US12269902B2Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2023·Granted Apr 8, 2025·1 cites·20 claims
- 0388US11034727B2Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2016·Granted Jun 15, 2021·6 cites·26 claims
- 0472US2025296957A1Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapyTRANSFERT PLUS SEC·Filed 2025·Application pending·0 cites
- 0555US2024156971A1Methods and sortilin binding conjugate compounds for targeting cancer stem cellsTRANSFERT PLUS SOC EN COMMANDITE·Filed 2022·Application pending·0 cites
- 0650US2023036041A1Sortilin binding conjugate compounds, compositions and uses thereof for treating cancerTHERATECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 0746US2022000971A1Methods and compounds for targeting sortilin receptors and inhibiting vasculogenic mimicryTRANSFERT PLUS SEC·Filed 2019·Application pending·0 cites
- 0841US2015290341A1Targeted iduronate-2-sulfatase compoundsANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 0940US2016213760A1Aprotinin-derived polypeptide-antibody conjugatesANGIOCHEM INC·Filed 2013·Application pending·0 cites
- 1036US2020157151A1Peptide compounds, conjugate compounds and uses thereof for treating inflammatory diseasesTRANSFERT PLUS SEC·Filed 2018·Application pending·0 cites
- 1135US2014335163A1Targeted iduronate-2-sulfatase compoundsANGIOCHEM INC·Filed 2012·Application pending·0 cites
- 1235US2015037311A1Targeted lysosomal enzyme compoundsANGIOCHEM INC·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean-Christophe Currie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →